尼莫地平中断与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的关系
结果显示尼莫地平中断与DCI发生率升高显著相关,且为DCI的独立预测因素。
要点
- 尼莫地平中断与aSAH后DCI发生率升高显著相关(ρ=0.431,P<0.001)。
- 仅20%(33/165)患者接受全剂量尼莫地平,中断者达51.5%。
- 尼莫地平中断是DCI的独立预测因素(OR 0.194,95%CI 0.079-0.474)。
核心结论
- 尼莫地平中断与aSAH患者DCI发生率升高相关,且为DCI的独立预测因素。
研究设计与样本
- 记录尼莫地平预防用药时长、剂量及DCI发生率,行Spearman相关和序数回归分析。
主要发现
- 165例(97.1%)从第0天开始尼莫地平预防,中断者85/165(51.5%),减量者47/165(28.5%),全剂量者仅33/165(20%)。
- DCI发生于85/170(50%)患者。
- 尼莫地平中断与DCI发生率升高显著相关(ρ=0.431,P<0.001);全剂量与DCI呈显著负相关(ρ=-0.273,P<0.001)。
- 序数回归显示尼莫地平中断是DCI的独立预测因素(OR 0.194;95%CI 0.079-0.474,P<0.001)。
关键数值与推荐
- 尼莫地平中断与DCI相关:ρ=0.431,P<0.001。
- 全剂量尼莫地平与DCI负相关:ρ=-0.273,P<0.001。
- 尼莫地平中断预测DCI:OR 0.194,95%CI 0.079-0.474,P<0.001。
临床怎么用
- aSAH患者应尽量避免中断尼莫地平预防用药,以降低DCI风险。
- 因血压下降而减量或中断尼莫地平需权衡DCI风险。
局限性
- 本研究为单中心回顾性分析,样本量170例,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines recommend the administration of nimodipine for the prevention of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). However, nimodipine can lead to significant drops in mean arterial pressure and cerebral perfusion pressure. Catecholamines are then used to maintain them while nimodipine is reduced and/or held. There is no evidence that nimodipine retains its neuroprotective effect at lower doses. We aimed to investigate the role of nimodipine interruption in the setting of aSAH and its possible impact on the incidence of DCI. METHODS: We performed a retrospective analysis in patients with aSAH admitted to our center from January 2012 to October 2015. Nimodipine prophylaxis duration and dosage and the incidence of DCI were recorded. Bivariate correlation with Spearman's rho (ρ) and ordinal regression analyses were performed. RESULTS: A total of 170 patients were included in the study. Of these, 165 (97.1%) received nimodipine prophylaxis starting on day 0. Nimodipine was interrupted in 85 of 165 (51.5%), whereas dose was reduced in 47 of 165 (28.5%); full dose was received by only 33 of 165 (20%). DCI was observed in 85 of 170 (50%). Nimodipine interruption correlated in a statistically significant way with a greater incidence of DCI (ρ = 0.431, P < 0.001); receiving full doses of nimodipine showed a statistically significant inverse correlation to DCI (ρ = -0.273, P < 0.001). Ordinal regression analysis revealed nimodipine interruption as a statistically significant independent predictor of DCI (odds ratio 0.194; 95% confidence interval 0.079-0.474, P < 0.001). CONCLUSIONS: Our analysis reveals a greater incidence of DCI in patients with aSAH when nimodipine is interrupted.
引用
- Hernández-Durán S, Mielke D, Rohde V, et al. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage? World Neurosurg. 2019. PMID: 31404696. doi:10.1016/j.wneu.2019.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。